Multaq (dronedarone) is a brand-name oral tablet prescribed to lower the risk of hospitalization for atrial fibrillation in certain adults. As with other drugs, Multaq can cause side effects that ...

Multaq (dronedarone) is a prescription drug used to help reduce the risk of a hospital stay for adults with a history of atrial fibrillation (AFib). The drug comes as an oral tablet that’s usually ...

The PALLAS trial of dronedarone (Multaq) for permanent AF has been stopped early, according to a press release (below) issued by Sanofi. PALLAS (Permanent Atrial fibriLLAtion outcome Study using ...

In an updated safety communication the FDA announced it was adding new warnings to the dronedarone (Multaq, Sanofi) label. Based on results from the PALLAS trial, which was discontinued early due to ...

- Benefit-risk of Multaq remains unchanged in non-permanent AF patients - Paris, France - July 7, 2011 - Sanofi (EURONEXT: SAN and NYSE: SNY) announced today that the company has discontinued the ...

Federal health officials have added new safety warnings to the heart rhythm drug Multaq after company studies linked the pill to higher rates of heart attack, stroke and death in a subset of patients.

Multaq may have hit a snag. The atrial fibrillation drug from Sanofi-Aventis, whose 2009 U.S. launch got off to a slow start, is the subject of an impending "Dear Doctor" letter to inform physicians ...

PARIS, March 22 (Reuters) - Sanofi-Aventis' Multaq drug for treating irregular heartbeat received a low score in an assessment by French authorities, La Tribune newspaper said on Monday. Multaq was ...

PARIS, Nov 16 (Reuters) - Sanofi's irregular heart beat drug Multaq will no longer be reimbursed by the French health system from December, in a further setback to a medicine once seen as a ...

Multaq (dronedarone) is a prescription drug used to reduce the risk of hospitalization in certain adults with atrial fibrillation (AFib). Multaq can cause side effects that range from mild to serious.

Multaq (dronedarone) is a brand-name drug prescribed to reduce the risk of hospitalization in certain adults with atrial fibrillation (AFib). Multaq comes as an oral tablet that’s typically taken ...